EMA Authorised: Lopinavir/Ritonavir Viatris (previously Ritonavir Mylan) (lopinavir;ritonavir) — Viatris Limited

View source ↗

Summary

The EMA has authorised Lopinavir/Ritonavir Viatris (lopinavir/ritonavir) for HIV infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• Lopinavir/ritonavir Viatris (lopinavir/ritonavir)

Snippet

Status: Authorised. Therapeutic area: HIV Infections. MAH: Viatris Limited. Decision date: 23/04/2026